Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation.
about
Current applications and different approaches for microbial l-asparaginase productionStabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profileCharacterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion.A multiple-dose pharmacokinetics of polyethylene glycol recombinant human interleukin-6 (PEG-rhIL-6) in rats.Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol.Pegylated arginine deiminase: a novel anticancer enzyme agent.Solubilization of native integral membrane proteins in aqueous buffer by noncovalent chelation with monomethoxy poly(ethylene glycol) (mPEG) polymers.Enzymatically activated near infrared nanoprobes based on amphiphilic block copolymers for optical detection of cancer.Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis.Pre-existing Antibody: Biotherapeutic Modality-Based Review.PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteinsDevelopment and testing of solid dose formulations containing polysialic acid insulin conjugate: next generation of long-acting insulin.Targeted Delivery of Protein Drugs by Nanocarriers.
P2860
Q28072068-7FDED8E5-670A-4F6F-9FCF-F3EC2A983AF0Q28544851-CA31BED9-3099-4432-9124-384C20B50E02Q33233070-49380DDC-1637-470C-8760-675EE2E939D3Q33393458-EC276352-6F0B-40F8-9FA2-F0C4A8A634DBQ34200694-DE2D735F-77A6-4CC6-9FF3-5070B14D781BQ34582086-1553D625-E076-4C78-B091-0ABA3CB1F329Q34911774-A4154FBC-7563-4EB7-B727-F185AD774BEFQ35178588-BD9505AF-996B-4BE1-9F17-AEA9F21A4C96Q35696721-19FC2E33-4C77-47C6-AA7C-50193A1AEFCAQ36039649-DAC604A4-5023-4D58-B0D7-B7B3E6BB38B0Q36653888-E2A92226-8F0E-4219-AA88-4A1FA37C8513Q37025675-D2993FD3-F5CD-449D-8948-9FA928C78A3FQ42735624-69861050-1A9A-4473-B509-9A13FDFDD73EQ54647504-9A4C4B4C-746B-4D61-A999-6A721229B345
P2860
Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@ast
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@en
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@nl
type
label
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@ast
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@en
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@nl
prefLabel
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@ast
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@en
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@nl
P1476
Modulation of the pharmacokine ...... lyethylene glycol conjugation.
@en
P2093
P304
P407
P577
2000-01-01T00:00:00Z